S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TSHA Taysha Gene Therapies Inc

1.75

0.00 (0.00%)

Pre Market

Last Updated: 03:39:48

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies Inc News

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 7 February 2025 (3 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 5 February 2025 (4 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 7 January 2025 (1 month ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 3 January 2025 (1 month ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 6 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (3 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
Wednesday 6 November 2024 (3 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (3 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Tuesday 22 October 2024 (4 months ago) • GlobeNewswire Inc.

More Taysha Gene Therapies Inc News Articles

ChainLink Token

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions